New Form 8-K - HARROW, INC. Filed: 2025-08-25 AccNo: 0001641172-25-025336 Size: 518 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year Item 9.01: Financial Statements …
iBio Announces Closing of $50 Million Public Offering
Biogen and Stoke Therapeutics Announce Presentations of Clinical Data from Studies of Zorevunersen for the Potential Treatment of Dravet Syndrome at the 36th International Epilepsy Congress
Beam Therapeutics to Participate in Upcoming September 2025 Investor Conferences
Xeris Announces Orange Book Listing of U.S. Patent forRecorlev®
I-Mab Announces the Appointment of Seasoned Biotech Executives to the Board of Directors and the Scientific Advisory Board, and the Formation of a Research and Development Committee
Alkermes to Present Detailed Positive Results From Vibrance-1 Phase 2 Study Evaluating Alixorexton in Patients With Narcolepsy Type 1 at World Sleep 2025
Stoke Therapeutics and Biogen Announce Presentations of Clinical Data from Studies of Zorevunersen for the Potential Treatment of Dravet Syndrome at the 36th International Epilepsy Congress
Castle Biosciences - New Evidence Published Supporting Use ofDecisionDx®-SCC Test in Guiding and Improving Treatment Pathway Decisions in NCCN High-Risk Cutaneous Squamous Cell Carcinoma
CollPlant to Participate in the Upcoming 27th Annual H.C. Wainwright Global Investment Conference
OmniAb - OmniAb Announces $30 Million Private Placement
OmniAb Announces $30 Million Private Placement
EDAP to Participate in the H.C. Wainwright 27th Annual Global Investment Conference
OmniAb Announces $30 Million Private Placement